• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调节性 T 细胞向 Th17 表型的促炎可塑性与老年原发性免疫性血小板减少症患者 TGFBR2 变体患病率升高一致。

Proinflammatory plasticity towards Th17 paradigm of regulatory T cells consistent with elevated prevalence of TGFBR2 variants in elderly patients with primary immune thrombocytopenia.

机构信息

Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.

Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.

出版信息

BMC Immunol. 2023 Apr 7;24(1):6. doi: 10.1186/s12865-023-00541-8.

DOI:10.1186/s12865-023-00541-8
PMID:37029342
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10082480/
Abstract

BACKGROUND

Primary immune thrombocytopenia (ITP) is characterized for the skewed Th differentiation towards Th1 and Th17 cells as well as the impaired number and function of regulatory T cells (Tregs). Tregs are capable of co-expressing effector Th markers in different inflammatory milieu, which probably indicates Treg dysfunction and incompetence to counter over-activated immune responses.

METHODS

Ninety-two primary ITP patients from March 2013 to December 2018 were included, and proinflammatory plasticity in different Treg compartments, age groups, and TGFBR2 variant carrier status were investigated.

RESULTS

Patients were categorized into elderly (n = 44) and younger (n = 48) groups according to an age of 50 years at disease onset. The overall remission rate was 82.6% after first-line regimens, including 47.8% complete remission. TGFBR2 variants were found in 7 (7.6%) patients with three V216I and four T340M heterozygote carriers. ITP patients demonstrated elevated co-expression of IL-17 and decreased co-expression of both IFN-γ and IL-13 than health control (all p < 0.01). The elderly group demonstrated elevated prevalence of TGFBR2 variants (p = 0.037) and elevated co-expression of IL-17 (p = 0.017) in Tregs, while female predominance was found in the younger group (p = 0.037). In the elderly group, TGFBR2 variant carriers demonstrated further elevated co-expression of IL-17 (p = 0.023) and decreased co-expression of both IFN-γ (p = 0.039) and IL-13 (p = 0.046) in the aTreg compartment.

CONCLUSIONS

Our findings revealed additional aberrations of Treg proinflammatory plasticity in elderly primary ITP patients, and highlighted the potential role of Treg dysfunction and senescence in the pathogenesis and management among these patients.

摘要

背景

原发免疫性血小板减少症(ITP)的特征是 Th 分化向 Th1 和 Th17 细胞倾斜,以及调节性 T 细胞(Treg)的数量和功能受损。Treg 在不同的炎症环境中能够共表达效应 Th 标志物,这可能表明 Treg 功能障碍和无能以对抗过度激活的免疫反应。

方法

纳入 2013 年 3 月至 2018 年 12 月的 92 例原发性 ITP 患者,研究不同 Treg 区室、年龄组和 TGFBR2 变体携带者状态的促炎可塑性。

结果

根据发病时年龄将患者分为老年(n=44)和年轻(n=48)组。一线方案治疗后总体缓解率为 82.6%,完全缓解率为 47.8%。发现 7 例(7.6%)患者存在 TGFBR2 变异,其中 3 例为 V216I,4 例为 T340M 杂合子携带者。与健康对照相比,ITP 患者 Treg 中 IL-17 的共表达增加,IFN-γ 和 IL-13 的共表达减少(均 p<0.01)。老年组 Tregs 中 TGFBR2 变异的发生率较高(p=0.037),IL-17 的共表达较高(p=0.017),而年轻组女性居多(p=0.037)。在老年组中,TGFBR2 变体携带者的 aTreg 区室中 IL-17 的共表达进一步增加(p=0.023),IFN-γ(p=0.039)和 IL-13(p=0.046)的共表达减少。

结论

我们的研究结果揭示了老年原发性 ITP 患者 Treg 促炎可塑性的额外异常,并强调了 Treg 功能障碍和衰老在这些患者发病机制和治疗中的潜在作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/436a/10082480/13571efeaf76/12865_2023_541_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/436a/10082480/4e3cd89c23e7/12865_2023_541_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/436a/10082480/13571efeaf76/12865_2023_541_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/436a/10082480/4e3cd89c23e7/12865_2023_541_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/436a/10082480/13571efeaf76/12865_2023_541_Fig2_HTML.jpg

相似文献

1
Proinflammatory plasticity towards Th17 paradigm of regulatory T cells consistent with elevated prevalence of TGFBR2 variants in elderly patients with primary immune thrombocytopenia.调节性 T 细胞向 Th17 表型的促炎可塑性与老年原发性免疫性血小板减少症患者 TGFBR2 变体患病率升高一致。
BMC Immunol. 2023 Apr 7;24(1):6. doi: 10.1186/s12865-023-00541-8.
2
Transcription Factor IRF4 Dysfunction Affects the Immunosuppressive Function of Treg Cells in Patients with Primary Immune Thrombocytopenia.转录因子 IRF4 功能障碍影响原发性免疫性血小板减少症患者 Treg 细胞的免疫抑制功能。
Biomed Res Int. 2019 Jul 10;2019:1050285. doi: 10.1155/2019/1050285. eCollection 2019.
3
Regulation of Th1/Th2 and Th17/Treg by pDC/mDC imbalance in primary immune thrombocytopenia.原发免疫性血小板减少症中 pDC/mDC 失衡对 Th1/Th2 和 Th17/Treg 的调控作用。
Exp Biol Med (Maywood). 2021 Aug;246(15):1688-1697. doi: 10.1177/15353702211009787. Epub 2021 May 2.
4
Neutralizations of IL-17A and IL-21 regulate regulatory T cell/T-helper 17 imbalance via T-helper 17-associated signaling pathway in immune thrombocytopenia.在免疫性血小板减少症中,IL-17A和IL-21的中和作用通过辅助性T细胞17相关信号通路调节调节性T细胞/辅助性T细胞17失衡。
Expert Opin Ther Targets. 2015 Jun;19(6):723-32. doi: 10.1517/14728222.2015.1016499.
5
Interleukin-17-producing CD4+ T lymphocytes are increased in patients with primary immune thrombocytopenia.原发性免疫性血小板减少症患者中产生白细胞介素-17的CD4 + T淋巴细胞增多。
Blood Coagul Fibrinolysis. 2016 Apr;27(3):301-7. doi: 10.1097/MBC.0000000000000423.
6
Inactivation of Notch signaling reverses the Th17/Treg imbalance in cells from patients with immune thrombocytopenia.Notch 信号失活可逆转免疫性血小板减少症患者细胞中的 Th17/Treg 失衡。
Lab Invest. 2015 Feb;95(2):157-67. doi: 10.1038/labinvest.2014.142. Epub 2014 Dec 8.
7
[Expression of interleukin-37, vascular endothelial growth factor A, and transforming growth factor-β1 and their correlation with T cells in children with primary immune thrombocytopenia].[白细胞介素-37、血管内皮生长因子A及转化生长因子-β1在儿童原发性免疫性血小板减少症中的表达及其与T细胞的相关性]
Zhongguo Dang Dai Er Ke Za Zhi. 2023 Nov 15;25(11):1131-1136. doi: 10.7499/j.issn.1008-8830.2306094.
8
Decreased TLR4 expression on monocytes may cause regulatory T cells abnormality in patients with primary immune thrombocytopenia.原发性免疫性血小板减少症患者单核细胞 TLR4 表达降低可能导致调节性 T 细胞异常。
Autoimmunity. 2017 Aug;50(5):283-292. doi: 10.1080/08916934.2017.1309034. Epub 2017 Apr 17.
9
PD-1/PD-L1 pathway activation restores the imbalance of Th1/Th2 and treg/Th17 cells subtypes in immune thrombocytopenic purpura patients.程序性死亡受体1/程序性死亡配体1(PD-1/PD-L1)通路激活可恢复免疫性血小板减少症患者Th1/Th2和调节性T细胞/辅助性T细胞17(Treg/Th17)细胞亚群的失衡。
Medicine (Baltimore). 2019 Oct;98(43):e17608. doi: 10.1097/MD.0000000000017608.
10
Involvement of levels of Toll like receptor-4 in monocytes, CD4+ T-lymphocyte subsets, and cytokines in patients with immune thrombocytopenic purpura.Toll 样受体 4 水平在免疫性血小板减少性紫癜患者单核细胞、CD4+ T 淋巴细胞亚群及细胞因子中的作用。
Thromb Res. 2013 Aug;132(2):196-201. doi: 10.1016/j.thromres.2013.04.025. Epub 2013 Jul 2.

引用本文的文献

1
Dysregulation and therapeutic prospects of regulatory T cells in type 1 diabetes.1型糖尿病中调节性T细胞的失调与治疗前景
Acta Diabetol. 2025 Mar 21. doi: 10.1007/s00592-025-02478-3.
2
YC-4-3, a Novel Glycogen Synthase Kinase 3β Inhibitor, Alleviates the Endoplasmic Reticulum Stress of Macrophages in Primary Immune Thrombocytopenia.新型糖原合酶激酶3β抑制剂YC-4-3减轻原发性免疫性血小板减少症中巨噬细胞的内质网应激
Adv Sci (Weinh). 2025 May;12(17):e2412515. doi: 10.1002/advs.202412515. Epub 2025 Mar 7.

本文引用的文献

1
Premature Senescence of T-cells Favors Bone Loss During Osteolytic Diseases. A New Concern in the Osteoimmunology Arena.T细胞过早衰老促进溶骨性疾病期间的骨质流失。骨免疫学领域的一个新关注点。
Aging Dis. 2021 Aug 1;12(5):1150-1161. doi: 10.14336/AD.2021.0110. eCollection 2021 Aug.
2
Prevalence of primary immune thrombocytopenia and related healthcare resource utilization among Texas Medicaid beneficiaries.德克萨斯州医疗补助受益人群中原发性免疫性血小板减少症的患病率及相关医疗资源利用情况。
Curr Med Res Opin. 2021 Aug;37(8):1315-1322. doi: 10.1080/03007995.2021.1923469. Epub 2021 Jun 21.
3
Recurrent germline mutations as genetic markers for aortic root dilatation in bicuspid aortic valve patients.
常染色体显性遗传基因突变作为二叶式主动脉瓣患者主动脉根部扩张的遗传标志物。
Heart Vessels. 2021 Apr;36(4):530-540. doi: 10.1007/s00380-020-01710-0. Epub 2020 Oct 16.
4
An update on the pathophysiology of immune thrombocytopenia.免疫性血小板减少症的病理生理学研究进展。
Curr Opin Hematol. 2020 Nov;27(6):423-429. doi: 10.1097/MOH.0000000000000612.
5
Dexamethasone suppresses the Th17/1 cell polarization in the CD4 T cells from patients with primary immune thrombocytopenia.地塞米松抑制原发性免疫性血小板减少症患者 CD4 T 细胞中 Th17/1 细胞的极化。
Thromb Res. 2020 Jun;190:26-34. doi: 10.1016/j.thromres.2020.04.004. Epub 2020 Apr 5.
6
Treg cells in health and autoimmune diseases: New insights from single cell analysis.健康与自身免疫性疾病中的调节性 T 细胞:单细胞分析的新见解。
J Autoimmun. 2020 Jun;110:102376. doi: 10.1016/j.jaut.2019.102376. Epub 2019 Dec 18.
7
Immune Thrombocytopenia.免疫性血小板减少症
N Engl J Med. 2019 Sep 5;381(10):945-955. doi: 10.1056/NEJMcp1810479.
8
The prediction value of Treg cell subtype alterations for glucocorticoid treatment in newly diagnosed primary immune thrombocytopenia patients.调节性 T 细胞亚群改变对初诊原发性免疫性血小板减少症患者糖皮质激素治疗的预测价值。
Thromb Res. 2019 Sep;181:10-16. doi: 10.1016/j.thromres.2019.07.001. Epub 2019 Jul 2.
9
Current and emerging treatments for immune thrombocytopenia.目前和新兴的免疫性血小板减少症治疗方法。
Expert Rev Hematol. 2019 Sep;12(9):723-732. doi: 10.1080/17474086.2019.1636644. Epub 2019 Jul 4.
10
The abnormal function of CD39 regulatory T cells could be corrected by high-dose dexamethasone in patients with primary immune thrombocytopenia.大剂量地塞米松可纠正原发免疫性血小板减少症患者调节性 T 细胞的异常功能。
Ann Hematol. 2019 Aug;98(8):1845-1854. doi: 10.1007/s00277-019-03716-9. Epub 2019 Jun 1.